4.5 Article

Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East

期刊

BONE MARROW TRANSPLANTATION
卷 56, 期 9, 页码 2144-2151

出版社

SPRINGERNATURE
DOI: 10.1038/s41409-021-01312-y

关键词

-

向作者/读者索取更多资源

The study analyzed the clinical outcomes of post-HCT patients who contracted COVID-19 in the Middle East. The results showed overall favorable clinical outcomes for patients, with those having more than 6 months from HCT to COVID-19 exhibiting lower admission rates and severity composite endpoint rates.
The coronavirus disease-2019 (COVID-19) caused by SARS Coronavirus 2 (SARS-CoV-2) is a potentially lethal infection. Cancer patients, and specifically hematopoietic cell transplant (HCT) recipients are severely immunocompromised and may be at a higher risk of a complicated course with this infection. We aimed to study the COVID-19 outcomes and severity in post HCT patients. We retrospectively reviewed post-HCT patients diagnosed with COVID-19 between March 15, 2020, and December 1, 2020 at 10 transplant centers across the Middle East. We identified 91 patients with confirmed SARS-CoV-2 infection across 10 transplant centers. The median age upon presentation with COVID-19 was 35. Fifty two patients were post allo-HCT while the remaining 39 patients were post auto-HCT. The median time from transplant was 14.9 months. Mortality rate was 4.4%. Hospital admission rate was 53%. ICU admission rate was 14%. Mechanical ventilation rate was 10%. Oxygen supplementation rate was 18%. Time from HCT to COVID-19 >6 months was associated with lower admission rates and lower rates of the severity composite endpoint. Antibody responses was seen 67% of evaluable patients. In this series of HCT recipients, we report overall favorable clinical outcomes for patients with COVID-19 and provide preliminary insights into the clinical course of this disease in this specific population.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Oncology

ASO Visual Abstract: Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer-A Comparative Nonrandomized Study

Shouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, Ali Aljubran, Ahmed Alzahrani, Aisha Alshibani, Reem Alrakaf, Tusneem Elhassan, Abdullah Alsuhaibani, Mahmoud A. Elshenawy

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study

Shouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, Ali Aljubran, Ahmed Alzahrani, Aisha Alshibani, Reem Alrakaf, Tusneem Elhassan, Abdullah Alsuhaibani, Mahmoud A. Elshenawy

Summary: The study found that prophylactic HIPEC and IORT after radical surgery for localized gastric or gastroesophageal cancer did not improve the risk of peritoneal recurrence.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Oncology

Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial

Shouki Bazarbashi, Ahmed Alzahrani, Ali Aljubran, Mahmoud Elshenawy, Ahmed Mostafa Gad, Fatima Maraiki, Noura Alzannan, Tusneem Elhassan, Ahmed Badran

Summary: This study aimed to test the alternating use of sunitinib and bevacizumab for advanced clear cell renal cell carcinoma patients. The results showed that adding bevacizumab to sunitinib treatment can continuously block angiogenesis and effectively inhibit tumor growth with manageable toxicity.

ONCOLOGIST (2023)

Article Medicine, General & Internal

Classification of Atypical White Blood Cells in Acute Myeloid Leukemia Using a Two-Stage Hybrid Model Based on Deep Convolutional Autoencoder and Deep Convolutional Neural Network

Tusneem A. Elhassan, Mohd Shafry Mohd Rahim, Mohd Hashim Siti Zaiton, Tan Tian Swee, Taqwa Ahmed Alhaj, Abdulalem Ali, Mahmoud Aljurf

Summary: Recent advancements in AI have led to the development of a computer vision model for morphological classification of atypical white blood cells in acute myeloid leukemia. This model utilizes geometric transformation and deep convolutional autoencoder techniques to achieve accurate and efficient classification.

DIAGNOSTICS (2023)

Article Critical Care Medicine

Comparison of Noninvasive Mechanical Ventilation With High-Flow Nasal Cannula, Face-Mask, and Helmet in Hypoxemic Respiratory Failure in Patients With COVID-19: A Randomized Controlled Trial

Abdul Hakeem Al Hashim, Abdullah Al Reesi, Nabil M. Al Lawati, Jyoti Burad, Murtadha Al Khabori, Juhi Chandwani, Redha Al Lawati, Yahya Al Masroori, Abdul Aziz Al Balushi, Salim Al Masroori, Khalsa Al Siyabi, Fatema Al Lawati, Faroug Yousif Nimer Ahmed, Merah Al Busaidy, Aisha Al Huraizi, Mahmood Al Jufaili, Jalila Al Zaabi, Jerin Treesa Varghese, Ruqaya Al Harthi, Kingsly Prabhakaran Sebastian, Fahad Hamed Al Abri, Jamal Al Aghbari, Saif Al Mubaihsi, Adil Al Lawati, Mujahid Al Busaidi, Giuseppe Foti

Summary: This study compared the effectiveness of high-flow nasal cannula (HFNC), helmet, and face-mask noninvasive ventilation in COVID-19 patients with respiratory failure. The study found no significant difference in intubation rate and mortality among the three techniques.

CRITICAL CARE MEDICINE (2023)

Review Oncology

Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients

Riad El Fakih, Abdulwahab A. Albabtain, Saud Alhayli, Khawlah Farhan, Walid Rasheed, Alfadel Alshaibani, Naeem Chaudhri, Mahmoud Aljurf

Summary: This study retrospectively analyzed the safety and efficacy of using CPIs for cHL relapses post-allo-HCT in six patients. The results showed that CPIs maintained efficacy without any new safety concerns, even in patients who had failed to benefit from CPIs prior to allo-HCT.

SEMINARS IN ONCOLOGY (2023)

Article Endocrinology & Metabolism

Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre

Shouki Bazarbashi, Mohamed Aseafan, Tasnim Elgazzar, Maha Alkhayat, Abdulrahman Alghabban, Marwa I. I. Abdelgawad, Bader Alshamsan, Aisha Alshibany, Tusneem Elhassan, Ali Aljubran, Ahmed Alzahrani, Hindi Alhindi, Hussein Raef

Summary: This study aims to report the clinicopathological feature, treatment patterns, and survival outcomes of GEP-NET patients in the Middle East. The most common tumor location in this region was the pancreas, followed by the small bowel, stomach, rectum, colon, and appendix. Around 54.2% of the patients had metastatic disease at diagnosis. Patients who underwent surgical resection as primary management had significantly better survival outcomes.

BMC ENDOCRINE DISORDERS (2023)

Review Medicine, General & Internal

Applications of Artificial Intelligence in Thrombocytopenia

Amgad M. Elshoeibi, Khaled Ferih, Ahmed Adel Elsabagh, Basel Elsayed, Mohamed Elhadary, Mahmoud Marashi, Yasser Wali, Mona Al-Rasheed, Murtadha Al-Khabori, Hani Osman, Mohamed Yassin

Summary: Thrombocytopenia is a medical condition characterized by a very low blood platelet count, which can be caused by various factors including medication, sepsis, viral infections, and autoimmunity. Early detection and evaluation of thrombocytopenia are crucial for prompt and appropriate intervention. Artificial intelligence has shown great potential in the early diagnosis, prognosis assessment, and prediction of thrombocytopenia distribution by simultaneously considering multiple variables.

DIAGNOSTICS (2023)

Review Hematology

Paraneoplastic syndromes associated with classic Hodgkin lymphoma, a systematic literature review

Riad El Fakih, Yazeed S. Bajuaifer, Amna Yousaf Shah, Reem Sulaiman, Rawan Almohamady, Ghada ELGohary, Haya S. Alothaimeen, Mahmoud Aljurf

Summary: Peripheral nervous system (PNS) manifestations of cancer, particularly in the context of classical Hodgkin lymphoma (cHL), are not well-studied. A systematic literature review was conducted, identifying 128 patients from 115 publications. Most patients had the nodular sclerosis (NS) subtype (66.4%). The most common clinical presentation of PNS was central nervous system (CNS) involvement (25.8%). The majority of patients were diagnosed with both cHL and PNS simultaneously (42.2%). The presence of PNS antibodies was reported in 35 patients (27.3%). Patients over 18 years old had a higher prevalence of PNS. The complete resolution rate of PNS was 54.7%. Relapse of lymphoma occurred in 13 patients, with PNS recurrence in 10 of them.

ANNALS OF HEMATOLOGY (2023)

Review Biophysics

Safety and efficacy of immune checkpoint inhibitors after allogeneic hematopoietic cell transplantation

Hanan Alkhaldi, Mohamed Kharfan-Dabaja, Riad El Fakih, Mahmoud Aljurf

Summary: The immune system is crucial in preventing infections and cancers, and impairment in immunity may contribute to the development of neoplasia. Immune evasion, including through checkpoint signaling pathways, plays a significant role in relapse after alloHCT. Checkpoint inhibitors have been approved for the treatment of relapsed cHL, PMBCL, and other solid tumors, but their use after alloHCT can lead to high rates of GVHD. The optimal timing, dosing, and patient selection for CPIs in post-alloHCT relapse remain uncertain.

BONE MARROW TRANSPLANTATION (2023)

Letter Biophysics

Lung transplantation for pulmonary graft versus host disease: experience from a referral organ transplantation center

Riad El Fakih, Rayid Abdulqawi, Amer Bugnah, Tarek Ziad Arabi, Walid Rasheed, Loui Ezzat, Marwan Shaheen, Naeem Chaudhri, Fahad Almohareb, Eid A. Al-Mutairy, Mahmoud Aljurf

BONE MARROW TRANSPLANTATION (2023)

Letter Biophysics

Contemporary outcomes of high risk relapsed refractory classical hodgkin lymphoma patients-role of maintenance therapy in the real world

Moussab Damlaj, Mohamed Tlayjeh, Ahmad Damlaj, Bader Alahmari, Husam AlSadi, Mazin Ahmed, Zied AlJubour, Ayman Alhejazi, Hend Salama, Ayman Ibrahim, Abdulrahman Al Raizah, Mohammed Bakkar, Abdulraouf Ghori, Abdullah S. Al Saleh, Ahmed Alaskar, Mohsen Alzahrani

BONE MARROW TRANSPLANTATION (2023)

Meeting Abstract Oncology

The Outcome of Tisagenlecleucel (Tisa-Cel) CD-19 CAR-T Cell Therapy in NHL Relapsed/Refractory Beyond Second Line of Therapy, Single-Center Data

Reem Alasbali, Abdulrahman Nasiri, Saud Alhayli, Naeem Chaudhri, Alfadel Alshaibani, Abdulwahab Albabtain, Syed Ahmed Osman, Walid Rasheed, Riad El-Fakih, Mahmoud Aljurf, Ali Alahmari

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)

暂无数据